Found 21 matching trials
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
PHASE3This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Location
Henan Cancer Hospital
Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers
PHASE3This is a randomized, multicenter, phase III trial comparing induction chem...
Location
Hôpital de la Pitié-Salpétrière
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
PHASE3This multicenter, open-label, randomized Phase III trial evaluates intensit...
Location
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
PHASE3This trial is a multi-center phase III clinical trial. The purpose of this ...
Location
First Affiliated Hospital, Sun Yat-Sen University
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
PHASE2This is a prospective, randomized, open-label, two-arm phase 2 trial that w...
Location
Froedtert & the Medical College of Wisconsin
TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC
PHASE3Through randomized controlled phase III multicenter clinical trials, TPF in...
Location
Cancer Hospital of Guizhou Medical University
GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China
PHASE2The present study is a randomized, control, phase II study of locally advan...
Location
Department of Radiation Oncology, Xijing Hospital, Fourth Military
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3The purpose of this study is to compare the survival and toxicity of GP (ge...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
NAThrough a prospective clinical trial, we intend to combine surgery, inducti...
Location
Sun Yat-sen University Cancer Center
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma
PHASE3This trial aimed to evaluate the efficacy of anlotinib hydrochloride combin...
Location
Multiple Locations